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ABSTRACT

A system for determination of intraocular pressure includes:
an intraocular pressure sensor; a light source illuminating
the sensor with one or more wavelengths of light; and a
detector that measures emitted light from the sensor. The
sensor includes a substrate member, a spacer member, and a
flexible membrane, which define a sealed cavity. The flexible membrane moves in response to intraocular pressure
changes. A device for measuring intraocular pressure
includes: the sensor; an anchoring member attached to the
sensor for immobilizing the sensor in an eye; and a protective member attached to the anchoring member and covering
the sensor to prevent contact between the flexible membrane
and the eye. A method for determination of intraocular
pressure includes: placing the sensor in an eye; illuminating,
with a light source, the sensor with one or more wavelengths
of light; and detecting, with a detector, a resultant light that
contains information about intraocular pressure.

Related U.S. Application Data

( 58)

1941829 A2
2007012008 A2

Dec. 30, 2010

US 2011/0160561 Al

(52)

G0lB 9/021
250/231.19

OTHER PUBLICATIONS

(57)
(65)

6/1962 Post
7/1971 Cindrich .

FOREIGN PATENT DOCUMENTS

Subject to any disclaimer, the term ofthis
patent is extended or adjusted under 35
U.S.C. 154(b) by 675 days.

Appl. No.: 12/982,110

*

(Continued)

Assignees: THE UNIVERSITY OF KENTUCKY
RESEARCH FOUNDATION,
Lexington, KY (US); BROCKMAN
HOLDINGS LLC, Louisville, KY
(US)

(21)

References Cited

(56)

Inventors: Jeffrey Todd Hastings, Lexington, KY
(US); E. Britt Brockman, Louisville,
KY (US); Ingrid L. St. Omer,
Lexington, KY (US); John C. Wright,
Louisville, KY (US)

Notice:

Patent No.:
US 10,687,704 B2
Date of Patent:
Jun.23,2020

7 Claims, 14 Drawing Sheets

2 1

203

204

US 10,687,704 B2
Page 2
( 58)

Field of Classification Search
USPC .......................................................... 600/398
See application file for complete search history.

(56)

References Cited

U.S. PATENT DOCUMENTS
3,962,921
4,089,329
4,158,310
4,428,239
4,499,373

A
A
A
A
A

4,523,597
4,573,778
4,589,286
4,665,747
4,682,500
4,922,913
4,926,696

A
A
A
A
A
A
A

4,933,545
5,005,577
5,329,321
5,375,595
5,515,864
5,517,313
5,817,075
6,193,656
6,443,893
6,544,208
6,555,011

A * 6/1990
A
4/1991
A
7/1994
A
12/1994
A
5/1996
A
5/1996
A
10/1998
Bl
2/2001
Bl
9/2002
B2
4/2003
Bl * 4/2003

6,571,119
6,579,235
6,712,764
6,890,300
6,939,299
6,981,958
7,202,947
7,252,006
7,284,442
7,510,699
7,678,065
7,762,664
7,854,174
2002/0162399
2003/0078487

B2
5/2003
Bl
6/2003
B2
3/2004
B2
5/2005
Bl
9/2005
Bl
1/2006
B2
4/2007
B2
8/2007
B2
10/2007
B2
3/2009
B2
3/2010
B2
7/2010
B2
12/2010
Al * 11/2002
Al * 4/2003

2004/0059248
2004/0254438
2006/0036138
2006/0241367
2007/0121120
2007/0123767
2007/0123768
2007/0129623
2008/0058632
2008/0154114
2009/0203985
2009/0299216
2010/0016704
2010/0042209
2010/0056952
2010/0106073
2010/0234717
2010/0280349
2010/0286498
2010/0294041
2011/0046452

Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al
Al

*
*

6/1976
5/1978
6/1979
1/1984
2/1985

*

6/1985
3/1986
5/1986
5/1987
7/1987
5/1990
5/1990

3/2004
12/2004
2/2006
10/2006
5/2007
5/2007
5/2007
6/2007
3/2008
6/2008
8/2009
12/2009
1/2010
2/2010
3/2010
4/2010
9/2010
11/2010
11/2010
11/2010
2/2011

Lips
Couvillon, Jr. et al.
Ho
Johnston .
73/705
Johnston ................. G0lL 23/16
250/231.19
Sawa et al.
Shapiro
Bethold
Muscatell
Uda
Waters et al.
Haritonidis
H04R23/008
250/231.19
Saaski et al.
250/227.14
Frenkel
Koizumi
Sinha et al.
Zuckerman
Colvin, Jr.
Giungo
Jeffries et al.
Schnakenberg et al.
Ethier et al.
Tribelsky .................. A61L 2/08
204/158.2
Hayashi
Abita et al.
Jeffries et al.
Lloyd et al.
Petersen et al.
Gharib et al.
Liu et al.
Tai et al.
Fleischman et al.
Black et al.
Haffner et al.
Fink
Aebersold et al.
Esashi et al.
73/715
Jeffries
A61B 3/16
600/398
Messner et al.
Roy et al.
Heller et al.
Koest
Schachar
Montegrande et al.
Freedman
Fleischman et al.
Tai et al.
Abraham et al.
Ehrecke
Chen et al.
Naber et al.
Guarnieri
Liu
Haffner et al.
Wismer
Dacquay et al.
Dacquay et al.
Tai et al.
Najafi et al.

OTHER PUBLICATIONS
ISA/KR, International Search Report and Written Opinion issued in
counterpart international application No.PCT/US2010/062523, dated
Aug. 30, 2011.

Sit, "Continuous Monitoring of Intraocular Pressure Rationale and
Progress Toward a Clinical Device," Journal Glaucoma, Apr.-May
2009, 18(4), pp. 272-279.
Kakaday et al., "Advances in Telemetric Continuous Intraocular
Pressure Assessment," British Journal of Ophthalmology, 2009, 93,
pp. 992-996, Epub Feb. 24, 2009.
Katuri et al., "Intraocular Pressure Monitoring Sensors," IEEE
Sensors Journal, Jan. 2008, 8(1), pp. 12-19.
Hill et al., "SU-8 MEMS Fabry-Perot Pressure Sensor," Sensors and
Actuators A, 2007, 138, pp. 52-62.
Walter, "Intraocular Pressure Sensor: Where are we-Where Will
we go?" Graefe's Arch Clin Exp Ophthalmol, 2002, 240, pp.
335-336.
Chow et al., "A Miniature-Implantable RF-Wireless Active Glaucoma Intraocular Pressure Monitor," IEEE Transactions on Biomedical Circuits and Systems, 2010, 4, pp. 340-349.
Chen et al., "Wireless Intraocular Pressure Sensing Using
Microfabricated Minimally Invasive Flexible-Coiled LC Sensor
Implant," Journal of Microelectromechanical Systems, 2010, 19,
pp. 721-734.
Faschinger et al., "Continuous 24 h monitoring of changes in
intraocular pressure with the wireless contact lens sensor Triggerfish
(TM). First results in patients," Ophtharnologue, 2010, 107, pp.
918-922.
Twa et al, "Evaluation of a Contact Lens-Embedded Sensor for
Intraocular Pressure Measurement," Journal of Glaucoma, 2010, 19,
pp. 382-390.
Doughty et al. "Human corneal thickness and its impact on intraocular
pressure measures: a review and meta-analysis approach." Survey
of Ophthalmology, 2000, 44, pp. 367-408.
Stangel et al. "A progranunable intraocular CMOS pressure sensor
system implant." IEEE Journal of Solid-State Circuits, 2001, 36, pp.
1094-1100.
Eggers et al. "Wireless intra-ocular pressure monitoring system
integrated into an artificial lens." 1st Annual International IEEEEMBS Special Topic Conference on Microtechnologies in Medicine
& Biology, Lyon, 2000, pp. 466-469.
Walter et al. "Development of a completely encapsulated intraocular
pressure sensor." Ophthalmic Research, 2000, 32, pp. 278-284.
Leonardi et al. "First steps toward noninvasive intraocular pressure
monitoring with a sensing contact lens." Investigative Ophthalmology & Visual Science, 2004, 45, pp. 3113-3117.
Wolbarsht et al. "A scleral buckle pressure gauge for continuous
monitoring of intraocular-pressure." International Ophthalmology,
1980, 2:3, pp. 11-17.
Chen et al. "Implantable micromechanical parylene-based pressure
sensors for unpowered intraocular pressure sensing." Journal of
Micromechanics and Microengineering, 2007, 17, pp. 1931-1938.
Chen et al. "Unpowered spiral-tube parylene pressure sensor for
intraocular pressure sensing." Sensors and Actuators A, 2006, 127,
pp. 276-282.
Chen et al. "Microfabricated Implantable Parylene-Based Wireless
Passive Intraocular Pressure Sensors." Journal ofMicroelectromechanical Systems, 2008, 17, pp. 1342-1351.
Chow et al "A 24-Hour Continuous IOP Monitoring Device Used
for the Treatment of Glaucoma in Humans." ARVO 2009 Annual
Meeting. Ft. Lauderdale, FL, 2009.
Chow et al. "A Miniature Implantable RF-Wireless Platform for
Active Glaucoma Intraocular Pressure Monitoring." ARVO 2008
Annual Meeting. Ft. Lauderdale, FL, 2008.
Rizq et al. "Intraocular pressure measurement at the choroid surface: a feasibility study with implications for implantable microsystems."
British Journal of Ophthalmology 2001,85, pp. 868-871.
Greene et al. Intraocular pressure measurement with instrumented
contact lenses. Investigative Ophthalmology & Visual Science,
1974, 13, pp. 299-302.
Cooper et al. "Passive radiotelemetry of intraocular pressure in
vivo: calibration and validation of continual scleral guard-ring
applanation transensor in dog and rabbit." Investigative Ophthalmology & Visual Science, 1979, 18, pp. 930-938.
Cooper et al. "Radio telemetry of intraocular pressure in vitro."
Investigative Ophthalmology & Visual Science, 1977; 16, pp.
168-171.

US 10,687,704 B2
Page 3
(56)

References Cited
OTHER PUBLICATIONS

Nissen, "Continuous recording of the intraocular pressure in human
and rabbit eyes with a simple applanating suction cup." Acta
Ophthalmologica 1977, 55, pp. 750-760.
Collins, "Minature passive pressure transensor for implanting in the
eye." IEEE Transactions on Biomedical Engineering, 1967, 14, pp.
74-83.
Backludn et al. "Passive silicon transensor intended for biomedical,
remote pressure monitoring." Sensors and Actuators, 1990, A2 lA23, pp. 58-61.
Flower et al. "Long-term continuous monitoring of intraocular
pressure in conscious primates." Ophthalmic Research, 1982, 14,
pp. 98-106.
Rosengren et al. "A system for wireless intra-ocular pressure
measurements using a silicon micromachined sensor." Journal of
Micromechanical and Microengineering 1992, 2, pp. 202-204.
Cooper et al. "Continual monitoring of intraocular pressure: effect
of central venous pressure, respiration, and eye movements on
continual recordings of intraocular pressure in rabbit, dog, and
man." British Journal of Ophthalmology 1979, 63. pp. 799-804.
McLaren et al. "Continuous measurement of intraocular pressure in

rabbits by telemetry." Investigative Ophthalmology and Visual
Science, 1996, 37, pp. 966-975.
Simons et al. "RF telemetry system for an implantable bio-MEMS
sensor." IEEE MTT-S International Microwave Symposium Digest,
2004, pp. 1433-1436.
Rosengren et al. "A system for passive implantable pressure sensors," Sensors and Actuators A, 1994, 43, pp. 55-58.
Akar et al. "A wireless batch sealed absolute capacitive pressure
sensor," Sensors and Actuator A, 2001, 95, pp. 29-38.
Coosemans et al. "A readout circuit for an intraocular pressure
sensor," Sensors and Actuators A, 2004, llO, pp. 432-438.
Lizon-Martinez et al. "Design of a system for continuous intraocular
pressure monitoring," Instrumentation and Measurement Technology Conference, 2004, IMTC 04, pp. 1693-1696.
Kakaday et al. "Design of a Wireless Intraocular Pressure Monitoring System for a Glaucoma Drainage Implant," ICBME 2008,
Proceedings 23, 2009, pp. 198-201.
EPO, Supplementary European Search Report issued in corresponding EP application No. 10841727.0, dated Feb. 24, 2014.
J. David Zook, et al., Optically excited self-resonant microbeams,
Sensors and Actuators A 52 (1996) 92-98.

* cited by examiner

U.S. Patent

Jun.23,2020

US 10,687,704 B2

Sheet 1 of 14

104
I

111

/

112

1
105

107

FlG, 1

U.S. Patent

Jun.23,2020

101

Sheet 2 of 14

US 10,687,704 B2

101
I

203

202

203

204

U.S. Patent

Jun.23,2020

US 10,687,704 B2

Sheet 3 of 14

I

I
d
0

300

xposition

FIG. 31\

FIG. 3B

1

0..5

]---<:J.I

0

II'!
(0

..r::.
o..
,_

-0.5

0
V)

a;

I.Ii

-1

-1.5
-2'"·····"'················································'························································'·························································"

10

15

20
25
30
Pressure (mm Hg)

FIG. 3C

35

40

I

301

U.S. Patent

Jun.23,2020

Sheet 4 of 14

US 10,687,704 B2

I

301

I

I

6

,

300

0 .____.__,-..,..._........__
0

x-pos!tion

o

;

I

_,___

kX

302

FIG. 4A

FIG. 4B

_,______,c..,

U.S. Patent

Jun.23,2020

Sheet 5 of 14

US 10,687,704 B2

U.S. Patent

Jun.23,2020

Sheet 6 of 14

/

500

600

'"-

0
FI(], 61\

r,1·c·"
- I3
r; __ .J. 6:

101

US 10,687,704 B2

U.S. Patent

Jun.23,2020

US 10,687,704 B2

Sheet 7 of 14
10'!

I

203 700

FIG. 7A

FIG. 7B

101

101

201

I

202

..,.
..,
.,..-'

.,r
✓.._.,;- ✓....,,.
,.,,...,..,..,.,,.
..

/

/"~/
/
.....
.,,.,.✓

,..

,..

..,.....,.,.

✓

//

✓

,,,.✓

,../.,-

✓ ✓✓./.....✓

...✓

,,,,.✓ /

,.,,.✓

,,,,,.....,..

/,..

700

203

FIG. 7C

700

203

FlG. 7D

/

202

U.S. Patent

Jun.23,2020

FIG. 8i\

Sheet 8 of 14

US 10,687,704 B2

FIG. 8B

U.S. Patent

Jun.23,2020

US 10,687,704 B2

Sheet 9 of 14

c::

C:
0

0

io

~oo

0
0.

0,

>-

'

>-,

,

300

0

,

x-pos1tion

300

I

0

x-position

301

301

o~~-.,,.._...,.-~-~-~-~
0

302

FIG. 9C

I
FIG. 9D

U.S. Patent

Jun.23,2020

Sheet 10 of 14

US 10,687,704 B2

1001

1000

I
d
0

300

x-position

FIG. lOA

FIG. 108

U.S. Patent

Jun.23,2020

Sheet 11 of 14

0.9Sr-----,----,-----,------,------,

US 10,687,704 B2

0.95.------,-----,-----,-----,-----,

og

I

0.6

0.6

(i.9

0.95

1

1.05

1.1

1.15

Separation between membran<e and floor<escer1t lay;,r (;,m)

FIG. l IA

05
· ?.9

0.95
1
1.05
1.1
1.1 5
Separation betw<een membrane and fluorescent layer (pm)

FIG. UB

/I
/4ependent of
0.9

--·-

_/

illumination angle

,uis~------~-------~--~
0.95
LOS
1.1
1.15
1.2
Sepamtion betwe;,r-1 membrane and fluorescent layer (f,m)

FIG. l IC

{)_9) ' - - ' - - - - ~ - - - - ' - - - - - ' - - - - - ' - - - - '
1.()5
1.1
0.95
l.15

Separation between membrane and fluorescent layer (11ml

flG. l lD

U.S. Patent

Jun.23,2020

US 10,687,704 B2

Sheet 12 of 14

FIG. 12

1200

\
Coating a layer
containing
fluorescent
material

l
S1202

S1212

Placing the intraocular pressure sensor in an eye

+

l

Positioning an
optical filter

,.

J,

S1204

~

r

Illuminating the intraocular pressure sensor

l
S1206

Detecting a resultant fight that contains
information about intraocular pressure

r
~

S1208

Performing a
phase calculation
on the image of
the interference
pattern

1
S1210

Correlating the
phase angles with
intraocular
pressure

i

S1214

U.S. Patent

Jun.23,2020

Sheet 13 of 14

US 10,687,704 B2

FIG. 13
1300

\
S1302

-

i-

Performing a phase calculation on the
interference pattern to determine phase angles
of the interference pattern

i
S1304

Correlating the phase angles with pressure

U.S. Patent

'-.,

Jun.23,2020

Sheet 14 of 14

'
• '---~v--·-•••••

FTC}. 14/\

US 10,687,704 B2

US 10,687,704 B2
1

2

SYSTEM, DEVICE, AND METHOD FOR
DETERMINATION OF INTRAOCULAR
PRESSURE

too large and complex, mostly irreversible, risky with regard
to biocompatibility, and/or error prone.
BRIEF SUMMARY OF THE INVENTION

CROSS-REFERENCE TO RELATED
APPLICATIONS
This application claims the benefit of U.S. Provisional
Patent Application No. 61/291,131, filed Dec. 30, 2009, the
entire disclosure of which is hereby incorporated by reference

10

STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH OR DEVELOPMENT
15

Subject matter described herein was made with U.S.
Government support under contract number SBAHQ-08-I0081 awarded by the Small Business Administration. The
government has certain rights in the described subject matter.

20

THE NAMES OF THE PARTIES TO A JOINT
RESEARCH AGREEMENT
Not applicable.

25

INCORPORATION-BY-REFERENCE OF
MATERIAL SUBMITTED ON A COMPACT
DISC
30

Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to systems, devices, and
methods for measuring pressure. More particularly, the
present invention relates to systems, devices, and methods
for measuring intraocular pressure.
2. Background Art
Devices that measure intraocular pressure (IOP) by measuring the applanation of the cornea are known in the art.
Ophthalmologists use such devices to measure IOP in a
physician's office. However, these single-point measurements remain insufficient to fully manage eye disease,
particularly glaucoma. IOP peaks are missed in office hours
measurements, IOP fluctuations may be an independent risk
factor, and a majority of glaucoma patients require changes
to their topical and/or surgical management approach after
multiple IOP measurements on a single day. Infrequent
measurements also make it difficult to evaluate treatment
effectiveness and/or to assess patient compliance. However,
more frequent, longer term tonometry is labor intensive,
impractical, expensive, and often conducted only upon
admission to an academic hospital. Tonometers that can be
used by the patient are know in the art, but these devices
often cause discomfort, have proven difficult for patients to
repeatably administer, and have demonstrated unacceptable
error in clinical studies.
Implantable electronic devices for more frequent measurement of intraocular pressure are known in the art.
Readout of passive electronic sensors has proven problematic because inductively coupling to tiny receivers in the
sensor is difficult. Active sensors overcome this problem, but
require implantable power sources or power storage systerns, implanted integrated circuits, and large antennas. As a
result, both passive and active systems have so far proven

35

40

45

50

55

60

65

According to one aspect of the invention, a system for
determination of intraocular pressure includes: an intraocular pressure sensor; a light source illuminating the intraocular pressure sensor with one or more wavelengths of light;
and a detector that measures reflected and/or emitted light
from the sensor. The intraocular pressure sensor includes a
substrate member, a spacer member, and a flexible membrane. The substrate member, the spacer member and the
flexible membrane define a sealed cavity. The flexible membrane moves and/or deforms in response to intraocular
pressure changes.
In accordance with one implementation, the system further includes a processing device in communication with the
detector. Then, the flexible membrane both transmits and
reflects the one or more wavelengths of light, the substrate
member reflects the one or more wavelengths of light
transmitted by the flexible membrane, the light reflected by
the substrate member interferes with light reflected from the
flexible membrane to create an interference pattern, and the
interference pattern corresponds to intraocular pressure.
According to this implementation, the detector is an electronic imaging device capturing an image of the interference
pattern, and the processing device performs a phase calculation on the image of the interference pattern to determine
phase angles of the interference pattern, and correlates the
phase angles with intraocular pressure.
The processing device may further perform the phase
calculation using an integral transform and may calculate the
phases at one or more spatial frequencies corresponding to
peaks in an absolute value of the integral transform.
Also, the processing device may use the values of the
spatial frequencies corresponding to peaks in the absolute
value of the integral transform to correct for errors which
arise from angular deviation of a sensor normal from an
optical axis of a readout system.
Still further, each wavelength emitted by the light source
may have a coherence length longer than the twice the
separation between the flexible membrane and the substrate
member.
According to this implementation, the system may further
include an optical filter positioned between the intraocular
pressure sensor and at least one of the light source and the
electronic imaging device. The optical filter provides an
optical coherence length greater than twice the distance from
the flexible membrane to the substrate member.
The light source may be modulated in time to allow for
lock-in detection of the interference pattern.
Further, the light source may emit multiple wavelengths
of light, either simultaneously or sequentially, and the
dimensions of the flexible membrane may allow a phase
change in the interference pattern of greater than 2it for at
least one of the multiple wavelengths of light.
In accord with another implementation, the system further
includes a processing device in communication with the
detector, a coating containing a fluorescent material coated
on at least one of the substrate member and the flexible
membrane, and a filter positioned between the intraocular
pressure sensor and the detector. An external light source
excites the fluorescent material of the coating, the fluorescent material of the coating emits a light of a different
second wavelength, the emission of the light of the second
wavelength being the result of excitation of the fluorescent

US 10,687,704 B2
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material, and the proximity of the flexible membrane to the
substrate member modulates the intensity of the emitted
light of a different second wavelength. The detector is a light
intensity sensor. The filter allows only the second wavelength to reach the detector. Then, the processing device
correlates the detected intensity at the second wavelength
with intraocular pressure.
According to another aspect of the invention, a device for
measuring intraocular pressure includes: an intraocular pressure sensor including a substrate member, a spacer member,
and a flexible membrane, the substrate member, the spacer
member and the flexible membrane defining a sealed cavity
wherein the flexible membrane moves and/or deforms in
response to intraocular pressure changes; an anchoring
member attached to the intraocular pressure sensor for
immobilizing the intraocular pressure sensor in an eye; and
a protective member attached to the anchoring member and
covering the intraocular pressure sensor to prevent contact
between the flexible membrane and portions of the eye.
In accordance with one implementation, the anchoring
member comprises a plate for insertion in a scleral pocket
and for immobilizing the device, and an arm for entering an
anterior chamber of the eye through a scleral tunnel. The
plate may include holes for suturing the plate to the eye,
and/or holes for assisting wound healing.
In accordance with another implementation, the anchoring member includes a pair of pincers to enclavate an iris of
the eye.
In accordance with yet another implementation, the
device further includes a second intraocular pressure sensor
having at least one of a different diameter, shape, membrane
thickness, membrane material, and substrate material, such
that the intraocular pressure sensor and the second intraocular pressure sensor provide at least one of redundant pressure
measurement, failure detection, compensation for temperature fluctuations in the eye, increased pressure measurement
sensitivity, and increased pressure measurement dynamic
range.
The anchoring member and the protective member may
be formed from a biocompatible material selected from a
group consisting of polymethylmethacrylate, other acrylic
plastics, silicone, other biocompatible plastics, biocompatible metals, and biocompatible metal alloys.
According to another aspect of the invention, an intraocular pressure sensor, includes: a substrate member; a spacer
member; and a flexible membrane. The substrate member,
the spacer member and the flexible membrane define a
sealed cavity, and the flexible membrane moves and/or in
response to intraocular pressure changes and the movement
of the flexible membrane can be measured optically.
In accordance with one implementation, the sealed cavity
has a pressure below one atmosphere.
In accordance with another implementation, light is both
transmitted and reflected by the flexible membrane, and
reflected by the substrate member, the light reflected by the
substrate member interferes with light reflected from the
flexible membrane to create an interference pattern, and the
resulting interference pattern corresponds to intraocular
pressure.
According to this implementation, material and dimensions of the flexible membrane may provide a number of
periods in the interference pattern to estimate phase within
±0.03 radians such that intraocular pressure can be measured
with an accuracy of 1 mm Hg over a range of 610 to 820
mmHg absolute pressure.
Also according to this implementation, the material and
dimensions of the flexible membrane may prevent the mem-

brane from contacting the bottom of the sealed cavity under
pressures encountered in the intraocular environment.
Further in accord with this implementation, the materials
and dimensions of the flexible membrane may limit pressure
measurement errors to less than 1 mm Hg in the presence of
temperature fluctuations from 32° C. to 36° C. typically
encountered in the intraocular environment.
Still further in accord with this implementation, the material and dimensions of the flexible membrane and the
thickness of the spacer member provide an interference
pattern without using a light source that relies on laser
action.
This implementation may further include a layer of additional material coated on the external side of the membrane,
with the thickness and refractive index of the additional
material equalizing the reflection from the flexible membrane and the substrate member.
Additionally, the material and dimensions of the membrane of this implementation may limit the phase change in
the interference pattern to less than 2it over a range of 610
to 820 mmHg absolute pressure.
In accordance with another implementation, the intraocular pressure sensor includes a coating containing a fluorescent material, the coating being coated on at least one of the
substrate member and the flexible membrane. An external
light source excites the fluorescent material of the coating,
and the fluorescent material of the coating emits a light of a
different second wavelength, the emission of the light of the
second wavelength being the result of excitation of the
fluorescent material. The proximity of the flexible membrane to the substrate member modulates the intensity of the
emitted light of a different second wavelength and the
detected intensity of the emitted light of the different second
wavelength is used to determine the pressure.
This implementation may further include a scattering
medium coated on at least one of the flexible membrane and
the substrate member.
Also, in accordance with this implementation, the coating
may further include a second fluorescent material, and the
external light source may further excite the second fluorescent material of the coating to emit a light of a different third
wavelength. Then, the difference in detected intensity of the
emitted light at the second and third wavelengths may be
used to determine the pressure.
According to another aspect of the invention, a method for
determination of intraocular pressure includes placing an
intraocular pressure sensor in an eye, the intraocular pressure sensor including a substrate member, a spacer member,
and a flexible membrane, the substrate member, the spacer
member and the flexible membrane defining a sealed cavity
wherein the flexible membrane moves and/or deforms in
response to intraocular pressure changes. The method further includes illuminating, with a light source, the intraocular pressure sensor with one or more wavelengths of light,
and detecting, with a detector, a resultant light that contains
information about intraocular pressure.
In accordance with one implementation, the flexible
membrane both transmits and reflects the one or more
wavelengths of light, the substrate member reflects the one
or more wavelengths of light transmitted by the flexible
membrane, and the light reflected by the substrate member
interferes with light reflected from the flexible membrane to
create an interference pattern. The interference pattern corresponds to intraocular pressure.
According to this implementation, detecting the resultant
light includes capturing, with an electronic imaging device,
an image of the interference pattern, and the method further
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includes: performing a phase calculation on the image of the
interference pattern to determine phase angles of the interference pattern; and correlating the phase angles with
intraocular pressure.
Then, this implementation may further include positioning an optical filter between the intraocular pressure sensor
and at least one of the light source and the electronic
imaging device, the optical filter providing an optical coherence length greater than twice the distance from the flexible
membrane to the substrate member.
According to this implementation, the step of illuminating
the intraocular pressure sensor includes modulating the light
source in time to allow for lock-in detection of the interference pattern by the electronic imaging device.
In accordance with another implementation, the method
further includes coating a layer containing fluorescent material on at least one of the substrate member and the flexible
membrane. Illuminating the intraocular pressure sensor
includes exciting the fluorescent material of the coating with
a light source such that the fluorescent material of the
coating emits a light of a different second wavelength, the
emission of the light of the second wavelength being the
result of excitation of the fluorescent material. Then, the
proximity of the flexible membrane to the substrate member
modulates the intensity of the emitted light of a different
second wavelength. Additionally, detecting the resultant
light includes detecting an intensity of the emitted light of
the different second wavelength to determine the pressure.
In accordance with another implementation, placing the
intraocular pressure sensor in the eye includes immobilizing
the intraocular pressure sensor in the eye using an anchoring
member attached to the intraocular pressure sensor. The
anchoring member may include a plate and an arm, and the
immobilizing the intraocular pressure sensor in the eye may
further include: inserting the plate into a scleral pocket of the
eye; and inserting the arm into an anterior chamber of the
eye through a scleral tunnel. Also, immobilizing the
intraocular pressure sensor in the eye may include suturing
the plate to the eye using holes in the plate.
According to another aspect of the invention, a method for
the determination of intraocular pressure uses an interference pattern produced by an intraocular pressure sensor. The
intraocular pressure sensor includes a substrate member, a
spacer member, and a flexible membrane. The substrate
member, the spacer member and the flexible membrane
define a sealed cavity; wherein the flexible membrane moves
and/or deforms in response to intraocular pressure changes.
The movement or deformation of the flexible membrane is
measured optically. Light from a light source, emitting one
or more wavelengths of light either simultaneously or
sequentially, is both transmitted and reflected by the flexible
membrane, and reflected by the substrate member. The light
reflected by the substrate member interferes with light
reflected from the flexible membrane to create an interference pattern. The method includes: performing, by a processing device, a phase calculation on the interference
pattern to determine phase angles of the interference pattern,
and correlating the phase angles with pressure. The phase
calculation may be performed using an integral transform
and the phases may be calculated at one or more spatial
frequencies corresponding to peaks in an absolute value of
the integral transform. Additionally, values of the spatial
frequencies corresponding to the peaks in the absolute value
of the integral transform may be used to correct for errors
which arise from angular deviation of a sensor normal from
an optical axis of a readout system.

Other features and advantages of the invention will be set
forth in, or apparent from, the detailed description of exemplary embodiments of the invention found below.
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BRIEF DESCRIPTION OF THE SEVERAL
VIEWS OF THE DRAWINGS
These and other features, aspects, and advantages of the
present invention will become better understood with regard
to the following description, appended claims, and accompanying drawings where:
FIG. 1 is a functional block diagram of an exemplary
system for determination of intraocular pressure, according
to the invention;
FIG. 2A and FIG. 2B are schematic cross-sectional views
of exemplary intraocular pressure sensors according to the
invention;
FIG. 3A is a representation of an image of an exemplary
interference pattern;
FIG. 3B is a graph of an absolute value of an integral
transform of the exemplary interference pattern of FIG. 3A;
FIG. 3C is a graph of an experimentally measured relationship between phase of an interference pattern and liquid
pressure for an exemplary intraocular pressure sensor;
FIG. 4A is another representation of an image of an
exemplary interference pattern;
FIG. 4B is a graph of an absolute value of an integral
transform of the exemplary interference pattern of FIG. 3A;
FIG. SA is a schematic perspective view of an exemplary
embodiment of a device for measuring intraocular pressure
according to the invention;
FIG. SB is a schematic sectional view of an eye with the
device of FIG. SA implanted therein;
FIG. 6A is a schematic plan view of another exemplary
embodiment of a device for measuring intraocular pressure
according to the invention;
FIG. 6B is a schematic plan view of an eye with the device
of FIG. 6A implanted therein;
FIG. 7A through FIG. 7D are schematic cross-sectional
views of exemplary intraocular pressure sensors according
to the invention further comprising a coating containing a
fluorescent material;
FIG. SA and FIG. 8B are representations of interference
patterns having a phase change of 2it;
FIG. 9A and FIG. 9B are representations of interference
patterns associated with multiple, sequentially emitted
wavelengths;
FIG. 9C and FIG. 9D are graphs of the absolute value of
integral transforms of the interference patterns of FIG. 9A
and FIG. 9B, respectively;
FIG. lOA is a representation of an interference pattern
associated with multiple, simultaneously emitted wavelengths;
FIG. 10B is a graph of the absolute value of the integral
transform of the interference pattern of FIG. lOA;
FIG. llA through FIG. llD are graphs showing a calculated ratio of resultant light power to incident light power as
a function of membrane-fluorescent coating separation;
FIG. 12 is a flow chart of an exemplary method for
determination of intraocular pressure according to the invention;
FIG. 13 is a flowchart of an exemplary method for the
determination of pressure from an interference pattern produced by an intraocular pressure sensor according to the
invention; and
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FIG. 14A and FIG. 14B are schematic perspectives view
of further exemplary embodiments of a device for measuring
intraocular pressure according to the invention.

pressure for an intraocular pressure sensor 101 with a silicon
substrate member 200, a silicon nitride flexible membrane
202, illuminated with a light emitting diode light source 102
at a wavelength of similar to 800 nm.
As shown in FIG. 3B, the processing device 107 (FIG. 1)
performs the phase calculation using an integral transform
and calculates the phase at one or more spatial frequencies
corresponding to peaks 301 in an absolute value of the
integral transform 302. This calculation further allows for
correction of pressure readings for angular deviations
between the optical axes of the detector 106 and the
intraocular pressure sensor 101, as described in more detail
below.
FIG. 4A shows an interference pattern 300 from a sensor
101 whose optical axis is tilted about the y-axis effectively
compressing the pattern along the x-direction.
FIG. 4B, discussed below, shows the absolute value of an
integral transform 302 of the interference pattern 300.
In an embodiment each wavelength emitted by the light
source 102 (FIG. 1) has a coherence length longer than twice
the separation between the flexible membrane 202 and the
substrate member 200 (FIGS. 2A and 2B). Having a sufficiently long coherence length ensures that the interference
pattern 300 (FIG. 3A) can be clearly captured by the detector
106 (FIG. 1). A shorter coherence length could be contemplated, but would reduce the visibility of the interference
pattern 300 and thus reduce the signal to noise ratio of the
detector 106 signal.
In an embodiment the light source 102 is a light emitting
diode. A light emitting diode is preferred because it emits a
narrow range of wavelengths such that the coherence length
of the incident light 103 and resultant light 113 is between
1 µm and 1000 µm. This is appropriate for the range of
sealed cavity 203 thicknesses described in more detail
below. Laser light sources also offer sufficiently long coherence lengths, but light emitting diodes offer greater eye
safety.
In the exemplary system 100 shown in FIG. 1, an optical
filter 105 is positioned between the intraocular pressure
sensor 101 and at least one of the light source 102 and the
detector 106. The optical filter 105 increases the coherence
length of at least one of the incident light 103 and resultant
light 113. The optical filter 105 is required if the light source
102 does not have an intrinsically long enough coherence
length. In a preferred embodiment the filter is positioned
immediately in front of the detector so as to block other light
not at the wavelength of the resultant light 113.
In a preferred embodiment the wavelengths of the incident light 103 are in the infrared spectral region so that the
incident light 103 remains invisible to the patient.
In an embodiment, the light source 102 is modulated in
time by a modulator 108 which also communicates with the
processing device 107. The modulator modulates the light
source by at least one of electrical or mechanical means or
some combination of electrical and mechanical means. The
modulator 108 has a frequency such that many cycles are
contained in a single intraocular pressure measurement. The
modulating signal can be any of several periodic signals,
such as a sine wave or square wave, that are familiar to those
skilled in the art. The signal from the modulator 108 is also
routed to the processing device 107 where it is combined
with the signal from the detector 106 for phase-locked (or
"lock-in") detection, a technique well known to those skilled
in the art of low-level signal measurements. This detection
method reduces noise that could be introduced by light
sources, for example room lights, other than the resultant
light 113.

DETAILED DESCRIPTION OF EXEMPLARY
EMBODIMENTS OF THE INVENTION
FIG. 1 shows an exemplary system 100 for frequent
measurement of intraocular pressure using an intraocular
(i.e., inside or within an eye) pressure sensor 101 which, in
use, would be implanted in an eye. The pressure is measured
optically by the system 100 using a light source 102 to
illuminate the intraocular pressure sensor 101 with one or
more wavelengths of incident light 103. A resultant light 113
(comprising reflected light or a combination of reflected and
emitted light) is captured by a detector 106 and the signal
from the detector 106 is processed by a processing device
107 to determine the intraocular pressure.
The exemplary system 100 further comprises an objective
lens 110, a beam splitter 104, an illuminating lens 111, and
a diffuser 112. The objective lens 110 performs at least one
of the functions of collecting light from the intraocular
pressure sensor 101 and forming an image of the intraocular
pressure sensor 101 on the detector 106. The beam splitter
104 allows light from the source 102 to reach the intraocular
pressure sensor 101 and the reflected light from the intraocular pressure sensor 101 to reach the detector 106. The
illuminating lens 111 and diffuser 112 provide well controlled, uniform illumination of the intraocular pressure
sensor 101. The exemplary system 100 further comprises an
atmospheric pressure sensor 109. The atmospheric pressure
sensor 109 communicates with the processing device 107 to
allow measurement of intraocular pressure with respect to
atmospheric pressure. The atmospheric pressure sensor 109
can be an optical pressure sensor 101 as described here or
one of several atmospheric pressure sensors known to those
skilled in the art of pressure measurement.
FIG. 2A shows an exemplary intraocular pressure sensor
101 comprising a substrate member 200, a spacer member
201, and a flexible membrane 202 which define a sealed
cavity 203. The flexible membrane 202 deflects in response
to changes in intraocular pressure and these changes can be
measured optically. The incident light 103 is both transmitted and reflected by the flexible membrane 202, and reflected
by the substrate member 200. The light reflected by the
substrate member 200 interferes either constructively or
destructively with light reflected from the flexible membrane
202 such that the resultant light 113 (FIG. 1) comprises an
interference pattern 300, as shown in FIG. 3A.
The interference pattern 300 consists of bright and dark
regions that are referred to as interference fringes. The
brightest and darkest levels of the interference pattern 300
are shown as solid and dashed contour lines in FIG. 3A.
These interference fringes change position when the flexible
membrane 202 deflects in response to intraocular pressure
changes as described in more detail below. Thus, the interference pattern 300 corresponds to intraocular pressure.
The interference pattern 300 is captured using the detector
106 (FIG. 1). In an embodiment the detector 106 is an
electronic imaging device such as a digital camera or
photodetector array. In an embodiment, the detector 106
communicates with a processing device 107 which performs
a phase calculation on the image of the interference pattern
300 and correlates the calculated phase angles with intraocular pressure.
FIG. 3C shows the experimentally measured relationship
between the phase of the interference pattern 300 and liquid
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In an embodiment the light source 102 emits multiple
wavelengths of light in order to improve at least one of the
precision and dynamic range of the pressure measurement.
This is particularly important for designs of the intraocular
pressure sensor 101 in which the deflection of the flexible
membrane 202 yields a phase change of greater than 2it.
FIG. SA and FIG. 8B show interference patterns 300
having a phase change of 2it.
A single wavelength measurement of a single intraocular
pressure sensor 101 (FIG. 1) would exhibit pressure ambiguities if the phase changes by more than 2it, as described
in more detail below.
FIG. 9A and FIG. 9B show interference patterns 300
associated with each wavelength captured by the detector
106 in an embodiment where multiple wavelengths are
emitted sequentially. The processing device 107 (FIG. 1)
calculates the phase angle of each interference pattern 300 at
spatial frequencies corresponding to the illuminating wavelengths as described in more detail below.
As shown in FIG. lOA, in an alternative embodiment the
light source 102 emits the multiple wavelengths simultaneously, and a more complex interference pattern 300 is
generated. The processing device 107 now calculate the
phase angles from a single interference pattern 300 but at
multiple spatial frequencies, each spatial frequency corresponding to a different wavelength, as described in more
detail below.
In yet another embodiment, as shown in FIG. 7A and FIG.
7B respectively, the intraocular pressure sensor 101 further
comprises a coating 700 containing a fluorescent material,
the coating 700 being coated on at least one of the substrate
member 200 and the flexible membrane 202. As used herein,
a fluorescent material is a material which absorbs electromagnetic energy of a specific first wavelength and re-emits
energy at different (but equally specific) additional wavelengths. A fluorophor is a component, such as a fluorescent
dye molecule, of a fluorescent material which absorbs electromagnetic energy of a specific first wavelength and reemits energy at different (but equally specific) second wavelength. A fluorescent material may contain one or more
fluorophors. The incident light 103 excites the fluorescent
material of the coating 700, and the fluorescent material of
the coating 700 emits light of a different second wavelength,
the emission of the light of the second wavelength being the
result of excitation of the fluorescent material. After passing
back through the flexible membrane, and perhaps being
further modulated, the emitted light of a different second
wavelength becomes the resultant light 113.
In an embodiment, the proximity of the flexible membrane 202 to the substrate member 200 modulates the
intensity of the resultant light 113. In an embodiment the
intensity of the resultant light 113 from the intraocular
pressure sensor 101 is modulated based on several phenomena described in more detail below. In an embodiment the
detector 106 is one or more light intensity sensors. The light
intensity sensors may be at least one of photodiodes or
photomultipler tubes. The signal from the detector 106
corresponds to intraocular pressure, and the processing
device 107 processes the signal to determine intraocular
pressure. In an embodiment the optical filter 105 is placed
between the intraocular pressure sensor 101 and the detector
106 such that only the second wavelength in the resultant
light 113 reaches the detector 106.
Movement of the intraocular pressure sensor 101 with
respect to the assembly containing the detector 106 must be
considered. The assembly may be at least one of a handheld

unit, a head mounted unit, and an eye glass mounted unit.
The assembly may or may not contain the light source 102.
In an embodiment relative motion is limited by providing
a target at which the patient gazes while the pressure
measurement is acquired. The target can be real structure or
a virtual image created using optics within the assembly.
Those skilled in the art have found that angular motions are
limited to less than 0.2 degrees during visual fixation.
In an embodiment an eye cup can be added to the
assembly containing the detector 106. The eye cup contacts
the face during the pressure measurement in order to physically limit movement of the intraocular pressure sensor 101
with respect to the detector 106.
In an embodiment, at least one of autofocus mechanisms
or image stabilization mechanisms, familiar to those skilled
in the art, are added to the assembly to minimize the
movement of the sensor 101 image and the detector 106.
In an embodiment the detector 106 is an electronic image
sensor with a frame rate in excess of 100 frames per second.
The frame rate allows images to be captured during times
when the sensor is in focus and within the field of view of
the electronic image sensor.
The processing device 107 is preferably at least one of a
dedicated electronic circuit, a microprocessor, a digital signal processor, or a programmable logic device. The processing device 107 may be either internal or external to the
assembly containing the detector 106. The processing device
is connected to the detector by at least one of a physical
electrical connection, a wireless connection, or a network
connection all of which are familiar to those skilled in the
art.
FIG. SA shows a device for measuring intraocular pressure comprising an intraocular pressure sensor 101 and an
anchoring member 500. The anchoring member comprises a
protective member 501, a plate 502, and an arm 503.
FIG. 5B shows an eye 505 with the device implanted
through the sclera 508 such that the intraocular pressure
sensor 101 is located in the anterior chamber 506 and is
visible through the cornea 507. The protective member 501
prevents the intraocular pressure sensor 101 from contacting
the cornea 507 in case of movement of the sensor toward the
cornea 507. The dimensions of the plate 502 are chosen so
that it can be fixed in a scleral pocket. Although other
dimensions could be contemplated, a long dimension of 1 to
5 mm and a short dimension of 1 to 3 mm are appropriate.
In one embodiment the plate 502 contains holes 504 for
suturing the anchoring member 500 to the sclera 508.
Although other dimensions could be contemplated, the
diameter of the holes should be greater than approximately
50 µm to permit an atraumatic needle and suture to pass.
In an embodiment the plate 502 contains holes 504 to
assist in wound healing. In this case the sclera 508 closes
through the holes to promote both healing and immobilization of the device. The dimensions of the arm 503 are such
that the arm can extend through a scleral tunnel placing the
intraocular pressure sensor 101 in a position within the
anterior chamber 506 such that the intraocular pressure
sensor 101 is visible through the cornea 507. Other dimensions could be contemplated, but an arm width of 1 to 2 mm
and an arm length of 2 to 7 mm are acceptable.
In an embodiment shown in FIG. 6A and FIG. 6B, the
anchor member 500 comprises a pair of 600 on at least one
end such that it can be attached to the iris 601 rather than
fixed in the sclera 508. In this embodiment the anchor
member 500 along with the attached intraocular pressure
sensor 101 is inserted into the anterior chamber 506 and
placed on the iris 601 such that it does not block the pupil
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An exemplary device with two intraocular pressure sensors 101 includes one sensor 101 with diameter similar to
300 um and flexible membrane thickness similar to 1.5 µm
and another sensor 101 with flexible membrane 202 diam5 eter similar to 600 um and flexible membrane 202 thickness
similar to 200 nm. The sensitivity of the two sensors 101 to
changes in pressure are 0.020 radians/mmHg and 0.074
radians/mmHg respectively from 730 mmHg to 780 mmHg.
For a desired dynamic range of 610 to 820 mmHg the first
10
sensor undergoes a total phase change of similar to 4.8
radians and the second sensor undergoes a total phase
change similar to 16 radians. In this exemplary case the first
sensor 101 provides a coarse measurement of pressure with
no ambiguity over the entire pressure range, and the second
15
sensor 101 provides a more sensitive measurement of pressure with ambiguity among several pressures within the
range. However, the first sensor 101 removes this ambiguity.
Using two sensors 101 allows intraocular pressure to be
20 measured with greater sensitivity without sacrificing
dynamic range. Other sensor designs can be contemplated
that would expand dynamic range without sacrificing sensitivity.
The anchoring member 500 is formed from materials that
25 are biocompatible when implanted in the eye. Possible
materials include polymethylmethacrylate, other acrylic
plastics, and silicone. These materials are commonly used
for intraocular lenses. In addition, biocompatible metals and
metal alloys containing elements such as gold or titanium
where 8 1 and 8 2 are the phases for the interference pattern 30 are possible materials for the anchoring member.
300 or the intensities associated with the fluorescence for the
As discussed above, FIG. 2A shows an intraocular presfirst and second sensor respectively. 8 01 and 802 are known
sure sensor 101 comprising a substrate member 200, a
reference phases for the interference pattern 300 or known
spacer member 201, a flexible membrane 202 which define
reference intensities associated with the fluorescence for the
a sealed cavity 203. The flexible membrane 202 deflects in
first and second sensor respectively. S 1 r and S2 r are the 35 response in response to intraocular pressure changes and the
sensitivities of the first and second sensor to changes in
deflection of the flexible membrane 202 can be measured
temperature, for example in radians/° C. or intensity/° C.,
optically. The substrate member 200 consists of at least one
SIP and S2P are the sensitivities of the first and second sensor
biocompatible metal, semiconductor, or insulator material.
to changes in pressure, for example in radians/mmHg or
The spacer member 201 consists of at least one biocompatintensity/mmHg, T is the temperature and T 0 is a known 40 ible metal, semiconductor, or insulator material. The spacer
reference temperature, and P is the pressure and P O is a
member 201 prevents fluid from penetrating into the sealed
known reference pressure.
cavity 203. In an embodiment the spacer member 200
An exemplary device with two intraocular pressure senmaterial is at least one of silicon, silicon nitride, and silicon
sors 101 includes one sensor with diameter similar to 300
dioxide. The spacer member 201 can be formed by one of
um and another with diameter similar to 400 um. The 45 several processes familiar to those skilled in the art of
flexible membrane 202 thickness is similar to 1.5 µm for
microfabrication including at least one of etching or depoboth sensors. The sensitivities of the two intraocular pressition.
sure sensors 101 to changes in pressure are similar to 0.020
In a preferred embodiment the sealed cavity 203 has a
radians/mmHg and 0.037 radians/mmHg respectively for
pressure below one atmosphere. The reduced cavity pressure
intraocular pressure ranges from 730 mmHg to 780 mmHg 50 reduces the temperature sensitivity of the device because
(10 to 50 mmHg above atmospheric pressure at sea level).
expansion or contraction of the gas inside the cavity will not
The sensitivity of the two sensors 101 to changes in temcreate large changes in the separation of the flexible memperature are similar to 0.014 radians/° C. and 0.023 radians/ 0
brane 202 from the substrate member 200. A sealed cavity
C. respectively. Thus, the interference patterns 300 from the
203 with reduced pressure can be formed by one of several
two sensors allow differentiation between changes in pres- 55 processes familiar to those skilled in the art of microfabrisure and temperature.
cation including at least one of vacuum contact bonding,
In an embodiment, the flexible membrane 202 deflection
vacuum anodic bonding, vacuum adhesive bonding, thermal
due to pressure changes is different for two sensors 101.
annealing, etching through release holes and low pressure
Pressure is determined by measuring the phase angles of the
chemical vapor deposition sealing of these holes, and getinterference patterns 300 from both sensors. If the phase 60 tering of residual gas in the cavity.
change for at least one of the interference patterns 300
The flexible membrane 202 is substantially impermeable
exceeds 2it the pressure can still be determined uniquely
to gas or liquid in order to maintain the integrity of the sealed
based on the phase of the other interference pattern. In
cavity 203 over the life of the intraocular pressure sensor
addition, if the desired dynamic range is kept constant, the
101. In a preferred embodiment, the flexible membrane 202
use of two sensors with higher sensitivity, but at least one 65 consists of silicon nitride. Silicon nitride is one of the best
with total phase change greater than 2it, can improve senknown moisture and gas barriers, with no measurable permeation, even at 1100° C.
sitivity and thus sensing precision and accuracy.

602. The tissue of the iris is enclavated by the pincers 600
to immobilize the anchor member 500 in the eye 505.
In an embodiment shown in FIG. 14A two or more
intraocular pressure sensors 101 can be included in the same
device. This provides redundant pressure measurements that
increase confidence in the pressure reported by the intraocular pressure measurement system 100. In addition, if one
sensor fails, the deviation in readings between the first
sensor and any additional sensors will serve as an indication
of the failure.
In an embodiment shown in FIG. 14B, the second
intraocular pressure sensor 101 has at least one of a different
diameter, shape, flexible membrane 202 thickness, flexible
membrane 202 material, and substrate member 200 material.
The two or more pressure sensors 101 provide at least one
of redundant pressure measurement, failure detection, compensation for temperature fluctuations in the eye, increased
pressure measurement precision, increased pressure measurement dynamic range. In this embodiment, the flexible
membrane 202 deflection due to temperature changes and
the flexible membrane 202 deflection due to pressure
changes are different for the two different sensors 101. Thus,
the pressure and temperature can be separately measured by
solving a set of simultaneous equations of the form:
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In an embodiment, an incident light 103 (FIG. 1) strikes
the intraocular pressure sensor 101 and is partially reflected
and partially transmitted by the flexible membrane 202. The
transmitted light is partially reflected by the substrate member 200. Reflected light from the flexible membrane 202 and
the substrate member 200 combine to form a resultant light
113. Light reflected by the substrate member 200 interferes
either constructively or destructively with light reflected
from the flexible membrane 202 to create an interference
pattern 300 (FIG. 3). The resulting interference pattern 300
corresponds to intraocular pressure, as described in more
detail below.
The substrate member 200 consists of a material with the
correct optical properties and surface finish to at least
partially reflect light at the illumination wavelength. The
substrate member 200 material is chosen from a group
including at least one ofbiocompatible metals, semiconductors, or insulators. In an embodiment, the substrate member
200 is made of polished silicon which is partially reflective
throughout the visible and near-infrared spectral region. In
another embodiment the substrate member 200 is made from
a glass, plastic, semiconductor, or oxide material. In another
embodiment, the substrate member 200 material is optically
transparent for visible wavelengths but is reflective at infrared wavelengths. In another embodiment, the substrate
member 200 is coated with another layer of material or
multiple layers of materials to render it reflective in the
infrared. In this way the sensor is transparent in the visible
spectral region but reflective in the infrared region to
improve the aesthetics of the sensor.
The flexible membrane 202 consists of a material with the
correct optical properties and correct thickness to partially,
but not entirely, reflect an incident light 103. In this way an
optical cavity is formed and an optical interference pattern
300 is generated. In one embodiment a flexible membrane
202 consists of at least one of silicon, silicon nitride, and
silicon dioxide. A flexible membrane 202 can be formed by
one of several processes familiar to those skilled in the art
of microfabrication including at least one of implantation,
oxidation, physical vapor deposition, chemical vapor deposition, and etching.
The interference pattern 300 consists of bright and dark
regions that are often referred to as interference fringes.
These interference fringes change position when the flexible
membrane 202 deflects with respect to the substrate member. The separation of these rings depends on the curvature
of the flexible membrane 202 surface. If the separation of the
flexible membrane 202 and the substrate member 200
changes then the rings shift in radial position. If the curvature of the flexible membrane 202 surface changes then the
spacing of the rings changes. The visibility, the difference in
intensity between brightest and darkest points divided by
sum of the intensities between the brightest and darkest
points, of the rings at the detector 106 is determined by the
separation of the substrate member 200 and the flexible
membrane 202 and the coherence length of the resultant
light 113.
The materials and dimensions of the flexible membrane
allow a number of periods in the interference pattern 300 and
sufficient deflection to detect clinically important changes in
intraocular pressure. In it known that intraocular pressure
changes of 1 mmHg have clinical significance in managing
glaucoma. In an exemplary sensor the flexible membrane
202 is circular with a diameter of 300 µm and a thickness of
1.5 µm. The sealed cavity 203 contains a vacuum. The
spacer member is greater than 5 µm thick but less than twice
the coherence length of the incident light 103. At 820 mmHg

absolute pressure (60 mmHg above atmospheric pressure at
sea level) the flexible membrane 202 deflects similar to 3.6
µm at its central point. This gives rise to 9 periods in the
interference pattern 300 when illuminated with an incident
light 103 of 800 nm wavelength. To measure intraocular
pressure from 10 to 60 mmHg with respect to atmospheric
pressure at elevations from sea level to 2000 m the sensor
101 measures absolute pressures from 610 mmHg to 820
mmHg. For a light source 102 emitting a single wavelength,
the interference pattern 300 is limited to a maximum phase
change of 2it over this pressure range. Thus the intraocular
pressure measurement system 100 must measure the phase
to ±0.03 radians to maintain an accuracy of 1 mmHg. With
a signal to noise ratio as low as 1, the standard deviation of
the phase estimate is similar to 0.01 radians when the signal
is captured using only 200x200 pixel electronic image
sensor. We define signal to noise ratio as the square of the
amplitude of the interference pattern 300 modulation
divided by the variance of an additive Gaussian noise. This
noise level is much larger and the image resolution much
smaller than what would be typically encountered in practice, thus the precision of the phase measurement is sufficient to detect clinically relevant changes in intraocular
pressure.
The material and dimensions of the flexible membrane
202 and the dimensions of the spacer layer 201 prevent the
membrane 202 from contacting the bottom of the sealed
cavity 203 under pressures encountered in the intraocular
environment. In an exemplary sensor 101 the flexible membrane 202 consists of non-stoichiometric, low-stress silicon
nitride with an elastic modulus similar to 200 GPa and a
Poisson ratio similar to 0.27. The flexible membrane 202
diameter is 300 µm and the flexible membrane 202 thickness
is 1.5 µm. The sealed cavity 203 contains a vacuum. At 820
mmHg absolute pressure (60 mmHg above atmospheric
pressure at sea level) the flexible membrane 202 deflects
similar to 3.6 µm toward the substrate member 200 at its
center. If the spacer member 201 is greater than 3 .6 µm thick
then the flexible membrane 202 will not contact the substrate
member 200. Other dimensions and materials could be
contemplated that also prevent contact between the flexible
membrane 202 and the substrate member 200.
In a preferred embodiment an intraocular pressure sensor
101 limits pressure measurement errors to 1 mmHg in the
presence of temperature fluctuations from 32° to 36°. This
range represents the approximate range of corneal temperature variation for ambient temperatures ranging from 18° C.
to 27° C. It is known that variations in corneal temperature
represent an upper bound on variations in the anterior
chamber. In an exemplary sensor 101 the flexible membrane
202 consists of non-stoichiometric, low-stress silicon nitride
with an elastic modulus similar to 200 GPa, a Poisson ratio
similar to 0.27, and a coefficient of thermal expansion
similar to 2.3xl o- 6 /° C. One skilled in the art of microfabrication will understand that the mechanical properties of
silicon nitride thin films can vary depending on deposition
conditions and stoichiometry, and that other mechanical
properties could be contemplated that would yield similar
behavior. The flexible membrane 202 diameter is 500 µm
and the flexible membrane 202 thickness is 0.5 µm. The
sealed cavity 203 contains a vacuum. The substrate member
200 and the spacer member 201 consist of silicon with a
coefficient of thermal expansion of2.6xl0- 6 /° C. The spacer
member is greater than 11 µm thick. The illumination
wavelength is 800 nm. At a normal intraocular pressure of
15 mmHg (735 mmHg absolute pressure at sea level) the
pressure measurement error with change in temperature is
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similar to 0.12 mmHg/° C. This restricts the measurement
error to less than ±0.25 mmHg under the anterior chamber
temperature fluctuations described above. In an embodiment, the intraocular pressure measurement system 100
indicates the pressure measurement is potentially erroneous
if extreme ambient temperatures are detected. In an embodiment, the pressure sensor 101 is calibrated for extreme
ambient temperatures. Other dimensions and materials could
be contemplated that also reduce temperature dependence to
acceptable levels.
In a preferred embodiment an intraocular pressure sensor
101 has a spacer member 201 with a thickness that provides
an interference pattern 300 without using a light source that
relies on laser action. The coherence length of the incident
light 103 must be longer than twice the thickness of the
sealed cavity 203. The spacer member 201 has a thickness
that ensures the separation of the flexible membrane 202 and
the substrate member 200 is less than half the coherence
length of the incident light 103. Laser light sources typically
have coherence lengths of greater than 1 mm. However, eye
safety concerns when using lasers indicate that a light
emitting diode light source is preferred. Light emitting
diodes have coherence lengths ranging from approximately
1 µm to 1000 µm. In an embodiment, an optical filter 105 is
used to further increase the coherence length of at least one
of the incident light 103 or the resultant light 113. In an
exemplary sensor the spacer member is less than 50 µm thick
so that the separation between the flexible membrane 202
and the substrate member 200 does not exceed 50 um and
thus an incident light 103 with a coherence length of less
than 25 µm can be used to form the interference pattern 300.
For an infrared light source 102 with a center wavelength of
800 nm this corresponds to a spectral bandwidth of approximately 25 nm. Other dimensions could be contemplated that
also allow light sources 102 not employing laser action to be
used. One skilled in the art of interferometry will understand
that there are subtle differences in definition of coherence
length and spectral bandwidth depending on the spectral
shape of the light, the criterion for bandwidth, and the
criterion for coherence. As such, one skilled in the art will
understand that the numbers given are representative and
that other criteria for coherence length could be conceived.
In one embodiment, shown in FIG. 2B, the intraocular
pressure sensor 101 further comprises one or more layers
204 of additional material coated on the external side of the
flexible membrane 202. This additional material has refractive index and thickness such that reflection from the membrane 202 is substantially equal to the reflection from the
substrate member 200. Equalizing the reflection from the
membrane 202 and substrate member 200 provides the
greatest interference pattern 300 visibility, where visibility is
defined as the ratio of the differences in the maximum and
minimum intensity in the interference pattern 300 to the sum
of the maximum and minimum intensity. As a result, the
signal to noise ratio of the captured interference pattern 300
will be maximized if all other conditions are equal. It is
important to note that for certain combinations of flexible
membrane 202 thickness and refractive index the additional
layer 204 is unnecessary because the reflection is intrinsically balanced. However, the thickness of the flexible membrane 202 is often determined by the pressure range and
sensitivity required, and cannot be freely adjusted based on
optical considerations. In an exemplary intraocular pressure
sensor 101 the substrate member 200 is silicon with refractive index similar to 3.7, the flexible membrane 202 is low
stress silicon nitride with refractive index similar to 2.2 and
thickness similar 350 nm, the additional layer 204 is one of

several polyp-xylylene) polymers with a refractive index
similar to 1.6 and a thickness similar to 150 nm, and the
illumination wavelength is similar to 800 nm. In this
example the interference pattern 300 visibility improves
from 0.48 without the additional layer 204 to 0.75 with the
additional layer 204 in place. Other materials with different
refractive indices and thicknesses could be conceived to
achieve a similar improvement.
In the case of a single intraocular pressure sensor 101
illuminated by a single wavelength of light, the phase
change of the interference pattern 300 is restricted to the less
than 2it over the range of pressures to be measured. In an
exemplary sensor the flexible membrane diameter is 300 µm
and the flexible membrane thickness is 1.5 µm. The wavelength of illumination is 800 nm. Over a range of absolute
pressures from 610 mmHg to 820 mmHg the sensor's 101
sensitivity is similar to 0.02 radians/mmHg and the interference pattern 300 undergoes a phase change of less than
2it. As a result, there is no ambiguity in the pressure
measurements between 610 mmHg and 820 mmHg. Other
dimensions and materials for the flexible membrane 202
could be contemplated that also restrict the phase change to
2it over a desired pressure range.
In the embodiment shown in FIG. 7A, the intraocular
pressure sensor 101 further comprises a coating 700 containing a fluorescent material on the substrate member 200.
A light source 102 excites the fluorescent material of the
coating 700 and the fluorescent material of the coating emits
a light of a different second wavelength. The proximity of
the flexible membrane 202 to the substrate member 200
modulates the intensity of the emitted light of a different
second wavelength and the detected intensity of the emitted
light of the different second wavelength is used to determine
the pressure. The coating 700 can be any material that is
intrinsically fluorescent or that has been dyed with a fluorescent component. An example coating could be a polymer,
such as poly-methyl methacrylate (PMMA), dyed with
fluorescent molecules, such as the near-infrared polymethine
dyes. In an embodiment both the polymer and the dye are be
transparent in the visible part of the spectrum for aesthetic
reasons. In an embodiment, both excitation and emission
wavelengths are in the near infrared to prevent the patient
from seeing the incident light 103 or resultant light 113
while the pressure is being measured. In another embodiment shown in FIG. 7B, the intraocular pressure sensor 101
further comprises a coating 700 containing a fluorescent
material on the flexible membrane 202.
The intensity of the resultant light 113 from the pressure
sensor 101 is modulated based on several phenomena. First
the intensity of incident light 103 that reaches the fluorescent
coating 700 is modulated. This occurs because of wave
optical effects typically described in terms of (1) interference of optical reflections from the membrane surfaces, the
fluorescent material surfaces, and the substrate and (2)
optical near-field and evanescent coupling across the sealed
cavity when the separation of the membrane and substrate
are on the order of the wavelength of light. When light is
transmitted through two or more partially reflective surfaces
it can interfere constructively and destructively depending
on the separation of the surfaces. As a result, the transmitted
power in the resultant light 103 depends on the separation of
the surfaces. In the pressure sensor 101 there are at least four
partially reflected surfaces: the two surfaces of the flexible
membrane 202; the interface of the fluorescent coating 700
with the sealed cavity 203; and the interface of the substrate
member 200 with the fluorescent coating 700. First, the
transmission of incident light 103 to the fluorescent coating

5

10

15

20

25

30

35

40

45

50

55

60

65

US 10,687,704 B2
17

18

700 is modulated by the separation between the flexible
membrane 203, which is partially reflective, and the fluorescent coating 700 on the substrate member 200. As the
transmitted power at the excitation wavelength changes, the
light emission from the fluorescent coating 700 is modulated
as well.
The same effects that modulate the intensity of incident
light 103 reaching the fluorescent coating 700 also modulates the resultant light 113. In addition, a significant fraction
of the light emitted by the fluorescent coating 700 is
reflected back into the material by total internal reflection. If
the refractive index of the fluorescent coating 700 is greater
than the underlying substrate member 200, then this light is
completely trapped in the fluorescent layer. In either case,
the evanescent electric field from the internally reflected
light extends a short distance beyond the interface between
the fluorescent coating 700 and the sealed cavity 203. If the
flexible membrane 203 is sufficiently close to the fluorescent
coating 700 (separation similar to wavelength) then light
that would otherwise be totally internally reflected in the
fluorescent coating 700 will couple into the flexible membrane 202. The strength of this coupling is strongly dependent on the separation of the two layers; thus, a change in
pressure that deflects the flexible membrane 202, alters the
fluorescent membrane 202-fluorescent coating 700 separation, and the light emission. Moreover, light will be trapped
in the flexible membrane 202 by total internal reflection.
In an exemplary pressure sensor 101, a substrate member
200 is coated with a fluorescent coating 700 with real
refractive index 1.7 and that is sufficiently thick and absorbing to absorb all of the excitation light. A flexible membrane
202 is separated from the fluorescent coating 202 by a sealed
cavity 203 containing vacuum. The pressure sensor 101 is
excited with the incident light 113 at wavelength of 770 nm
in the near infrared and the fluorescent coating 700 emits at
800 nm. For explanatory purposes, the incident light 103 is
normally incident, unpolarized, and collimated, and the
fluorescence yield (or quantum efficiency) is 1. The resultant
light 113 emitted from the fluorescent coating 700 is unpolarized and has a diffuse (Lambertian) distribution.
FIG. llA shows a calculated ratio of resultant light 113
power to incident light 103 power as a function of membrane
202-fluorescent coating 700 separation. This ratio is a direct
measure of membrane 202 deflection and thus a measure of
pressure.
The pressure sensor 101 need not operate with collimated
incident light 103 or with normally incident light 103.
However, the output of the pressure sensor 101 is dependent
on the angle of illumination, cp.
FIG. llB shows a calculated ratio of resultant light 113
power to incident light 103 power as a function of membrane
202-fluorescent coating 700 separation with an illumination
angle of 10 degrees from normal. The relationship is different and this angle dependence must either be calibrated out
of the pressure reading or eliminated by a more sophisticated
sensor design described in more detail below.
In an embodiment shown in FIG. 7C, the flexible membrane 203 is also coated with a scattering medium 701 on the
side of the membrane external to the sealed cavity 203 to
enhance light emission from the sensor 101 and minimize
illumination angle dependence, as further described below.
An example of such a scattering medium is polytetrafluoroethylene. Modulation of the incident light 103 reaching
the fluorescent layer and modulation of the resultant light
113 exiting the sensor are both governed by the phenomena
described above. The scattering medium 701 serves two
purposes. First the scattering medium 701 randomizes the

angle of incident light 103 to reduce output dependence on
the angle of illumination. Secondly, the scattering medium
701 serves to extract light from the flexible membrane 202
and the fluorescent coating 700 that would otherwise be
trapped by total internal reflection. This both increases the
total amount of light emitted by the sensor and alters the
relationship between the amount of resultant light 113 and
the flexible membrane 202-fluorescent coating 700 gap.
In an alternative embodiment, shown in FIG. 7D, the
scattering medium 701 is placed on the surface of the
flexible membrane 202 inside the sealed cavity 203. This
configuration can improve light extraction from the fluorescent material because the scattering medium 701 is in a
region of greater evanescent electric field strength.
In an exemplary sensor a scattering medium 701 is coated
on the flexible membrane 202 surface external to the sealed
cavity 203. Both incident light 103 and emitted light are
diffusely (Lambertian) scattered at the membrane surface.
As a result, the ratio of incident light 103 power to resultant
light 113 power is no longer dependent on angle of illumination. However, the angle of illumination will affect the
total input power coupled into to the sensor.
FIG. llC plots the calculated ratio ofresultant light 113
power to incident light 103 power as a function of flexible
membrane 202-fluorescent coating 700 separation with the
scattering medium 701 on the external side of the flexible
membrane 202. This relationship is independent of illumination angle.
In an embodiment, the fluorescent coating 700 is placed
in the flexible membrane 202, rather than on the substrate
member 200, as shown in FIG. 7B. This embodiment is
governed by the same phenomena; however, interference
effects, near field effects, and evanescent coupling are all
modified by the position of the fluorescent coating 700 in
relation to the other sensor components. Specifically, light is
trapped in the combined structure of the fluorescent coating
700 and the flexible membrane 202, and is evanescently
coupled to the substrate member 200 depending on the
fluorescent coating 700-substrate member 200 separation.
In another embodiment of the exemplary intraocular
pressure sensor 101, two different fluorophors are contained
in the fluorescent coating 700, and the two fluorophors emit
light at two different wavelengths. The detector 106 measures the ratio of optical power at the two different wavelengths. In an embodiment the detector comprises a dichroic
beam splitter and two light sensors. Each light sensor detects
only one wavelength. In another embodiment, the detector
comprises a beam splitter, two optical filters, and two light
sensors. Again, each light sensor detects only one wavelength. By measuring the difference in detected optical
power between the two sensors, the pressure measurement
system 101 can compensate for different excitation and
emission efficiencies that occur when the eye moves relative
to the light source 102 and the detector 106 during or
between measurements.
In an exemplary sensor 101 the fluorescent coating 700
emits at two wavelengths, 800 nm and 900 nm. When both
fluorophors are excited, the ratio of the detected intensity
between the two wavelengths corresponds to intraocular
pressure. In this way we need not know the excitation power
for any given measurements.
FIG. llD plots the ratio oflight detected at 800 nm to that
detected at 900 nm as a function of the flexible membrane
202-fluorescent coating 700 separation.
As shown in FIG. 12, an exemplary method 1200 for
determination of intraocular pressure, includes the steps of:
S1202 placing an intraocular pressure sensor 101 (FIG. 1) in
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an eye (e.g., eye 505 of FIG. 5B), the intraocular pressure
sensor 101 including a substrate member 200, a spacer
member 201, and a flexible membrane 202, the substrate
member 200, the spacer member 201 and the flexible
membrane 202 defining a sealed cavity 203 wherein the
flexible membrane 202 moves and/or deforms in response to
intraocular pressure changes; S1204 illuminating, with a
light source 102, the intraocular pressure sensor 101 with
one or more wavelengths oflight; and S1206 detecting, with
a detector, a resultant light that contains information about
intraocular pressure.
In an embodiment, the flexible membrane 202 (FIG. 2)
both transmits and reflects the one or more wavelengths of
light, the substrate member 200 reflects the one or more
wavelengths of light transmitted by the flexible membrane
202, the light reflected by the substrate member 200 interferes with light reflected from the flexible membrane 202 to
create an interference pattern 300, and the interference
pattern 300 corresponds to intraocular pressure.
In an embodiment, the step S1206 detecting the resultant
light includes capturing, with an electronic imaging device,
an image of the interference pattern 300, and the method
further comprises a step S1208 performing a phase calculation on the image of the interference pattern 300 to
determine phase angles of the interference pattern 300; and
a step S1210 correlating the phase angles with intraocular
pressure.
In an embodiment, the method further comprises a step
S1212 positioning an optical filter 105 between the intraocular pressure sensor 101 and at least one of the light source
102 and the electronic imaging device, the optical filter 105
providing an optical coherence length greater than twice the
distance from the flexible membrane 202 to the substrate
member 200.
In an embodiment, the step of S1204 illuminating the
intraocular pressure sensor includes modulating the light
source 102 in time to allow for lock-in detection of the
interference pattern 300 by the electronic imaging device.
In an embodiment, the method further comprises a step
S1214 coating a coating 700 containing fluorescent material
on at least one of the substrate member 200 and the flexible
membrane 202, wherein the step S1204, illuminating the
intraocular pressure sensor, includes exciting the fluorescent
material of the coating 700 with a light source 102 such that
the fluorescent material of the coating 700 emits a light of a
different second wavelength, the emission of the light of the
second wavelength being the result of excitation of the
fluorescent material, wherein the proximity of the flexible
membrane 202 to the substrate member 200 modulates the
intensity of the resultant light 113 of a different second
wavelength, and wherein the step S1206 detecting the resultant light, includes detecting an intensity of the resultant
light 113 of the different second wavelength to determine the
pressure.
In an embodiment, the step S1202, placing the intraocular
pressure sensor in an eye, further includes immobilizing the
intraocular pressure sensor 101 in the eye 505 using an
anchoring member 500 attached to the intraocular pressure
sensor 101.
In an embodiment, the anchoring member 500 comprises
a plate 502 and an arm 503, and immobilizing the intraocular
pressure sensor 101 further includes inserting the plate 502
into a scleral pocket of the eye 505; and inserting the arm
503 into an anterior chamber 506 of the eye through a scleral
tunnel.

In an embodiment, immobilizing the intraocular pressure
sensor in the eye further includes suturing the plate 502 to
the eye using holes 504 in the plate 502.
As shown in FIG. 13, an exemplary method 1300 for the
determination of pressure from an interference pattern 300
produced by an intraocular pressure sensor 101 comprising
a substrate member 200; a spacer member 201; and a flexible
membrane 202; the substrate member 200, the spacer member 201 and the flexible membrane 202 defining a sealed
cavity 203; wherein the flexible membrane 202 moves
and/or deforms in response to intraocular pressure changes
and the movement or deformation of the flexible membrane
202 is measured optically, wherein light from a light source
102, emitting one or more wavelengths of light either
simultaneously or sequentially, is both transmitted and
reflected by the flexible membrane 202, and reflected by the
substrate member 200, and wherein the light reflected by the
substrate member 200 interferes with light reflected from the
flexible membrane 202 to create an interference pattern 300,
the method includes the steps of: S1302 performing, by a
processing device 107, a phase calculation on the interference pattern 300 to determine phase angles of the interference pattern 300; and S1304 correlating the phase angles
with pressure.
An exemplary interference pattern 300 has intensity, I,
that is periodic with the square of the spatial variables. An
exemplary signal of this type is I(x, y)=A cos(k,x 2 +kyy 2 )+B
where A is the amplitude of the fringe modulation, ~ and Is,
are the spatial frequencies of the rings in the x- and y-directions, x and y are the spatial coordinates across the sensor
surface, and B is constant offset of zero light level. In
practice, this signal may be discretely sampled by an electronic imaging device so that the pixel value at the j th ,kth
location in the image matrix is given by I1k=A cos(~x/ +
kyy/)+B.
To determine the phase of the interference pattern 300, the
two-dimensional image is multiplied by a kernel of the form
K(kx,ky,x, y)=exp [-ikxx2 -i]s, y 2 ]. For each value of~ and
kY the product of the signal and kernel is integrated over x
and y to yield the integral transform given by :S(~,]s,)=Jjl(x,
y)exp [-j~x 2 -jkyy 2 ]dxdy. FIG. 3B shows the absolute value
of the integral transform 302, IF(kx,ky)I. As can be seen in
FIG. 3B, there is a peak value 301 in IF(~,]s,)I at a particular
non-zero pair of values for~ and ky- At this peak value 301,
the phase angle of the transform
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will relate to how the rings are spatially positioned. Because
the spatial position of the rings in the interference pattern
300 is related to the deflection of the flexible membrane 202
with respect to the substrate member 200, one can determine
intraocular pressure from the phase of the transform at the
spatial frequencies corresponding to the peak 301. A change
in the phase of the transform indicates a shift in position of
the rings and thus a change in pressure. In an embodiment,
the transform is computed discretely and becomes
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where N is the number of pixels in the x-direction and Mis
the number of pixels in the y-direction.
In an embodiment, the spatial frequencies are known and
the transform need only be computed for one value ofkx and
one value of ]s,. In an embodiment, the spatial frequencies
are not known, and the integral transform is computed for a
range of spatial frequencies, the peak 301 in the absolute
value of the integral transform 302 is identified, and the
phase is computed at the spatial frequencies corresponding
to the peak 301.
FIG. 3C plots the phase at the peak 301 of IF(kx,ky)I as a
function of pressure for experimentally obtained data. The
sensor was placed in a sealed chamber with water around it,
and the pressure was varied with a syringe. The pressure
values on the abscissa were measured with a commercial
analog pressure sensor placed in the same test chamber as
the optical sensor. It is apparent that phase is correlated with
pressure, and that the sensor covers a range of physiologically relevant pressures found in the human eye (5-30
mmHg). In addition, this sensor design covers this range of
pressures relative to atmospheric pressure without exceeding a phase change of 2it and there is no ambiguity in the
phase-pressure relationship.
In an embodiment, the normal axis of the intraocular
pressure sensor 101 is not required to be coincident with the
optical axis of at least one of the light source 102 and
detector 106. The interference pattern 300 is spatially compressed along the direction associated with the tilt angle of
the sensor 101. For example, if the patient looks to the side
during a pressure measurement, the sensor 101 will rotate
about the y-axis and the interference pattern 300 will appear
to compress in the x-direction. Compression of the interference pattern 300 in space shifts the peak 301 in IF(kx,ky)I to
a higher spatial frequency. Thus, one can determine the
angle of the sensor 101 with respect to the optical axis of the
readout system from the values ofkx and ky- This allows one
to correct for any error that would otherwise be introduced
by the patient not looking directly along the optical readout
axis. FIG. 4A shows an interference pattern 300 with the
sensor rotated by 25 degrees about its y-axis. This rotation
is extreme, but is used for exemplary purposes to make the
fringe compression appear clear by visual inspection. FIG.
4B shows the absolute value of the integral transform 302,
IF(~,]s,)I. In this case, the peak 301 shifts to higher values
of kx because of the rotation.
In an embodiment, at least one of a larger range of
pressures needs to be measured or greater sensitivity, i.e.
phase change with change in pressure, is required. Two
wavelengths of light illuminate the sensor 101. In an
embodiment, the wavelengths illuminate the sensor sequentially so the interference pattern 300 from each wavelength
is measured separately. FIG. 9A and FIG. 9B show two
interference patterns 300 for sequential measurement of a
sensor with wavelengths of700 nm and 900 nm respectively.
FIG. 9C and FIG. 9D show the absolute value of the integral
transforms 302 for 700 nm and 900 nm wavelengths respectively. The peak values 301 occur at different spatial frequencies for the two different wavelengths. Calculating the
phase at the spatial frequencies corresponding to each peak
301 in each transform allow unambiguous determination of
the pressure even if the phase change of one or both
interference patterns 300 exceeds 2it.
In an embodiment, the two wavelengths illuminate the
sensor simultaneously, and a single interference pattern 300
is captured by the detector 106. FIG. l0A shows the interference pattern 300 and FIG. 10B shows the absolute value
of its integral transform 302 when the sensor is simultane-

ously illuminated with wavelengths of 700 nm and 900 nm.
In this case the two wavelengths result in a peak 1000 for
900 nm and a peak 1001 for 700 nm in a single integral
transform. The shorter wavelength yields a higher spatial
frequency. The two phases associated with the two wavelengths can be used to track phase changes larger than 2it
without ambiguity in the relationship between phase and
pressure. This method can increase the dynamic range of a
sensor or allow a certain dynamic range to be maintained
while redesigning the sensor for greater sensitivity.
Thus, the invention provides systems, devices, and methods for measuring intraocular pressure. One of ordinary skill
in the art will recognize that additional steps and configurations are possible without departing from the teachings of
the invention. This detailed description, and particularly the
specific details of the exemplary embodiment disclosed, is
given primarily for clearness of understanding and no
unnecessary limitations are to be understood therefrom, for
modifications will become evident to those skilled in the art
upon reading this disclosure and may be made without
departing from the spirit or scope of the claimed invention.
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What is claimed is:
1. An intraocular pressure sensor for implantation in an
eye, comprising:
a substrate member; a spacer member; and a flexible
membrane;
the substrate member, the spacer member and the flexible
membrane forming the walls of a sealed cavity having
no openings for fluid communication with a vacuum,
and forming the intraocular pressure sensor configured
for implantation in the eye;
the flexible membrane configured to deform in response
to intraocular pressure changes and wherein the deformation of the flexible membrane can be measured
optically;
the flexible membrane configured to partially transmit and
partially reflect an incident light that is incident on an
exterior surface of the flexible membrane when the
intraocular pressure sensor is implanted in the eye, and
the substrate member configured to reflect the incident
light that is partially transmitted by the flexible membrane back through the flexible membrane;
wherein the incident light reflected by the substrate member interferes with incident light reflected by the flexible membrane to create a resultant light comprising an
interference pattern consisting of bright and dark rings
having a separation depending on a curvature of the
flexible membrane;
wherein the resulting interference pattern is capturable as
an image using a camera and corresponds to intraocular
pressure; and wherein the sealed cavity has a pressure
below one atmosphere.
2. The intraocular pressure sensor of claim 1, wherein the
material dimensions of the flexible membrane provide a
number of periods in the interference pattern to estimate
phase within ±0.03 radians such that intraocular pressure can
be measured with an accuracy of 1 mm Hg over a range of
610 to 820 mmHg absolute pressure.
3. The intraocular pressure sensor of claim 1, the material
and dimensions of the flexible membrane configured to
prevent the membrane from contacting the bottom of the
sealed cavity under pressures encountered in the intraocular
environment.
4. The intraocular pressure sensor of claim 1, the materials
and dimensions of the flexible membrane configured to limit
pressure measurement errors to less than 1 mm Hg in the
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presence of temperature fluctuations from 32° C. to 36° C.
encountered in the intraocular environment.
5. The intraocular pressure sensor of claim 1, wherein the
material and dimensions of the flexible membrane and the
thickness of the spacer member provide the interference
pattern without using a light source that relies on laser
action.
6. An intraocular pressure sensor for implantation in an
eye, comprising:
a substrate member; a spacer member; and a flexible
membrane;
the substrate member, the spacer member and the flexible
membrane forming the walls of a sealed cavity having
no openings for fluid communication with a vacuum,
and forming the intraocular pressure sensor configured
for implantation in the eye;
the flexible membrane configured to deform in response
to intraocular pressure changes and wherein the deformation of the flexible membrane can be measured
optically;
the flexible membrane configured to partially transmit and
partially reflect an incident light that is incident on an
exterior surface of the flexible membrane when the
intraocular pressure sensor is implanted in the eye, and

the substrate member configured to reflect the incident
light that is partially transmitted by the flexible membrane back through the flexible membrane;
wherein the incident light reflected by the substrate member interferes with incident light reflected by the flexible membrane to create a resultant light comprising an
interference pattern consisting of bright and dark rings
having a separation depending on a curvature of the
flexible membrane; and
wherein the resulting interference pattern is capturable as
an image using a camera and corresponds to intraocular
pressure; and
further comprising a layer of additional material coated on
the external side of the flexible membrane, the thickness and refractive index of the additional material
configured to equalize the incident light reflected by the
substrate member and the incident light reflected by the
flexible membrane.
7. The intraocular pressure sensor of claim 1, the material
and dimensions of the membrane configured to limit the
phase change in the interference pattern to less than 2it over
a range of 610 to 820 mmHg absolute pressure.
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